It's a significant update but definitely a second order issue compared to the readout of the efficacy study. Any mention on the call about Covid possibly impacting inspection of their manufacturing facility?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.